Cited by 216Gut microbiota and healthSleep and Wakefulness ResearchRegulation of Appetite and Obesity

Butyrate, a metabolite of intestinal bacteria, enhances sleep

Open access
Szentirmai, Éva, Millican, Nicklaus S., Massie, Ashley R., Kapás, Levente·2019·Scientific Reports

Abstract

Emerging evidence suggests that the intestinal microbiota is a source of sleep-promoting signals. Bacterial metabolites and components of the bacterial cell wall are likely to provide important links between the intestinal commensal flora and sleep-generating mechanisms in the brain. Butyrate is a short-chain fatty acid produced by the intestinal bacteria by the fermentation of nondigestible polysaccharides. We tested the hypothesis that butyrate may serve as a bacterial-derived sleep-promoting signal. Oral gavage administration of tributyrin, a butyrate pro-drug, elicited an almost 50% increase in non-rapid-eye movement sleep (NREMS) in mice for 4 hours after the treatment. Similarly, intraportal injection of butyrate led to prompt and robust increases in NREMS in rats. In the first 6 hours after the butyrate injection, NREMS increased by 70%. Both the oral and intraportal administration of butyrate led to a significant drop in body temperature. Systemic subcutaneous or intraperitoneal injection of butyrate did not have any significant effect on sleep or body temperature. The results suggest that the sleep-inducing effects of butyrate are mediated by a sensory mechanism located in the liver and/or in the portal vein wall. Hepatoportal butyrate-sensitive mechanisms may play a role in sleep modulation by the intestinal microbiota.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-019-43502-1

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SCFAs are associated with a variety of diseases such as rectal cancer, pancreatitis, abnormal energy metabolism, constipation, blood lipid metabolism, sleep disorders and Alzheimer's disease.

    “Studies have found that SCFAs are associated with a variety of diseases such as rectal cancer, 174 pancreatitis, 175 abnormal energy metabolism, 176 constipation, 177 blood lipid metabolism, 178 sleep disorders 179 and Alzheimer's disease.180”

    From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [179]

    Citation 179 is attached to “sleep disorders,” not the other conditions in the list. The Introduction and Discussion (page unavailable) report that butyrate, an SCFA, increased sleep in mice and rats. They do not establish an association with sleep disorders, so the cited evidence supports a link to sleep but not the disease-specific claim. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • The influence of the gut microbiota is not restricted to the gastrointestinal tract; it plays a major role in bidirectional communication between the gastrointestinal tract and the central nervous system.

    “it plays a major role in the bidirectional communication between the GI tract and the central nervous system (CNS).”
  • SCFAs enhance sleep, suppress the activity of orexigenic neurons that express neuropeptide Y in the hypothalamus, and modulate signaling triggered by the ghrelin receptor, contributing to circadian rhythm and appetite control.

    “Further, SCFAs show effects on several neural functions, such as enhancing sleep (10), suppressing the activity of orexigenic neurons that express neuropeptide Y in the hypothalamus (89), and modulating the signaling triggered by the ghrelin receptor (129), contributing to circadian rhythm and appetite control.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Szentirmai, É., Millican, N. S., Massie, A. R., & Kapás, L.
Affiliations
Washington State University Spokane (US)
Corresponding author
Szentirmai, Éva
Venue
Scientific Reports
Published
2019-05-07
Volume
9
Issue
1
Pages
7035-7035
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2944574897
Cited by
216
References
65
Citations by year
2026: 19 · 2025: 33 · 2024: 47 · 2023: 34 · 2022: 32 · 2021: 27 · 2020: 22 · 2019: 2
FWCI
6.87
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL122390)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
butyrate, short-chain fatty acids, gut microbiota, sleep, NREM sleep, tributyrin, gut-brain axis, body temperature, bacterial metabolites, sleep regulation
MeSH terms
Gastrointestinal Microbiome, Administration, Oral, Animals, Butyrates, Injections, Mice, Inbred C57BL, Sleep, Triglycerides, Rats, Sprague-Dawley, Butyric Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review